Send Message
Shanghai fine-chemistry CO., Ltd 86-21-17617767348-1 jyzhang@api-chem.com
LGD 4033 SARMS Selective Androgen Receptor Modulator CAS 1165910-22-4 For Fat Loss

LGD 4033 SARMS Selective Androgen Receptor Modulator CAS 1165910-22-4 For Fat Loss

  • High Light

    muscle gain powder

    ,

    nolvadex tamoxifen citrate

  • Product Name
    LGD-4033
  • CAS
    1165910-22-4
  • MF
    C14H12F6N2O
  • Heavy Metals
    338.25
  • Appearance
    Not More Than 10ppm
  • Loss On Drying
    Not More Than 0.5%
  • Place of Origin
    China
  • Brand Name
    RUN
  • Certification
    ISO9001
  • Model Number
    RUN-AH
  • Minimum Order Quantity
    10g
  • Price
    inquiry
  • Packaging Details
    10g 50g 100g 500g 1kg
  • Delivery Time
    3-7 days
  • Payment Terms
    T/T, , MoneyGram, BTCcoin
  • Supply Ability
    1kg --100kg

LGD 4033 SARMS Selective Androgen Receptor Modulator CAS 1165910-22-4 For Fat Loss

Raw Fat Loss Sarms Powder LGD-4033 CAS 1165910-22-4, selective Androgen Receptor Modulators Steroids
 
Details

 

Product name LGD-4033, 4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile
CAS No. 1165910-22-4
MF C14H12F6N2O
MW 338.25
Purity 99.5%
Product categories SARMs(Selective androgen receptor modulator)
Appearance White crystalline powder
Molecular structure 99.2% LGD-4033 SARM CAS 1165910-22-4 Potent Non-Steroidal Bodybuilding Supplement
LGD-4033 Usage A Potent, Non-Steroidal Bodybuilding Supplement
usage hormone secretagogue

 

Description

 

LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It’s in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.

 

LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers. This randomized, double-blind, placebo-controlled Phase I study established the safety and tolerability up to doses of 22 mg per day.

 

Application

 

LGD is still fairly new (3-5 years), but the results have been very similar in studies and logs. LGD-4033 has undergone several recent studies and trials to find the best and safest way to use it. From these trials, the results have shown increases in lean body mass and decreases in body fat. There is also a significant increase in strength, well being, as well as healing possibilities.

 

LGD has shown the most ability of any SARM to put on size that could be considered a bulk. This will, of course, be dependent upon the diet used. Users that have experienced more than 10lb. increases, and have had a significant increase in calorie intake. The possibility of this type of size is present with LGD use. A recommend dosage for this type of goal would be 5-10 mg day for 8 weeks.

 

LGD seems to shine with this method. Many have seen an increase in lean body mass and a decrease in body fat. LGD seems to work the best with this method. Ran in conjunction with other SARMS, like cardarine (GW-501516), will only increase the likelihood of a stronger recomp. Recommended doses for recomping would be 5-8 mg a day for 8 weeks.

LGD can be used to cut as well. It will shine more-so if ran in conjunction with SARMS S-4 and Cardarine (GW-501516). This would be similar to a SARMS triple stack that is normally ran with Ostarine, except there is a possibility of more size being put on while cutting. A good dose for this method would be 3-5 mg a day for 8 weeks.

 

Specification

 

COA:

 

Test Items Standards Results
Description White crystalline powder Conforms
HNMR H group on the peak of the correct attribution Conforms
Loss on drying Not more than 0.5% 0.3%
Heavy metals Not more than 10ppm Conforms
Assay(HPLC) ≥98% 99.5%
Conclusion : Compliance with the requirements